Compare MC & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MC | MMED |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | 1416 | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.1B |
| IPO Year | 2014 | 2026 |
| Metric | MC | MMED |
|---|---|---|
| Price | $66.71 | $11.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $72.88 | $22.56 |
| AVG Volume (30 Days) | ★ 823.8K | 577.4K |
| Earning Date | 04-29-2026 | 06-03-2026 |
| Dividend Yield | ★ 3.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.28 | $15.99 |
| Revenue Next Year | $17.22 | $10.00 |
| P/E Ratio | $89.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $51.06 | $10.65 |
| 52 Week High | $78.22 | $17.86 |
| Indicator | MC | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 60.01 | 48.16 |
| Support Level | $61.62 | $10.65 |
| Resistance Level | $72.54 | $12.19 |
| Average True Range (ATR) | 2.00 | 0.74 |
| MACD | 0.19 | 0.15 |
| Stochastic Oscillator | 80.03 | 76.62 |
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. It generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States, followed by Europe and the rest of the World.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.